Saturday, February 11, 2012

Posts tagged with the keyword: ‘neph fda medical’

Nephros (OTC:NEPH): Three FDA Decisions, One Company

Nephros (OTC:NEPH): Three FDA Decisions, One Company

Nephros, Inc. (OTC: NEPH) A reader of StocksHaven Investments by the name of Michael Sklar has contributed the following article regarding Nephros, Inc. The article outlines one of the most undervalued BioPharma companies around, at only $1.08 PPS with three pending FDA decisions. If you are an avid investor of pre-PDUFA companies, StocksHaven Investments highly [...]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo